ASX Share rice
Sun 16 May 2021 - 01:26:am (Sydney)

PIQ Share Price

PROTEOMICS INTERNATIONAL LABORATORIES LTDPIQPharmaceuticals, Biotechnology & Life Sciences

PIQ Company Information

Name:

Proteomics International Laboratories Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

QEII Medical Centre Perth WA Australia 6009

Phone:

61 8 9389 1992

Co-Founder, MD & Director:

Dr. Richard John Lipscombe M.A., Ph.D., Ph.D., (London), MA (Oxford)

Head of Bus. Devel.:

Mr. John Chuck Morrison

Company Sec.:

Ms. Karen Teresa Logan B.Com., FCIS, BCom, DipAppCorpGov, FFin, ACIS, AGI

Company Overview:

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma, the primary common form of oesophageal cancer in Australia. The company was founded in 2001 and is based in Perth, Australia.

PIQ Share Price Information

Shares Issued:

105.21M

Market Capitalisation:

$123.09M

Revenue (TTM):

$2.38M

Revenue Per Share (TTM):

$0.03

Earnings per Share:

$-0.026

Profit Margin:

-1.011

Operating Margin (TTM):

$-1.22

Return On Assets (TTM):

$-0.24

Return On Equity (TTM):

$-0.37

Quarterly Revenue Growth (YOY):

-0.366

Gross Profit(TTM):

$2.67M

Diluted Earnings Per Share (TTM):

$-0.033

PIQ CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-1,586,133

Change To Liabilities:

$612.27K

Total Cashflow From Investing Activities:

$-1,586,133

Net Borrowings:

$-164,921

Net Income:

$-1,743,770

Total Cash From Operating Activities:

$-384,508

Depreciation:

$363.71K

Other Cashflow From Investing Activities:

$-127,825

Change To Account Receivables:

$136.81K

Sale Purchase Of Stock:

$3.05M

Capital Expenditures:

$1.46M

PIQ Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-1,743,770

Net Income:

$-1,743,770

Gross Profit:

$1.59M

Operating Income:

$-1,720,760

Other Operating Expenses:

$528.82K

Interest Expense:

$8.91K

Total Revenue:

$1.61M

PIQ Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$1.01K

Total Liabilities:

$1.12M

Total Stockholder Equity:

$4.44M

Other Current Liabilities:

$265.69K

Total Assets:

$5.55M

Common Stock:

$13.39M

Other Current Assets:

$1.14M

Retained Earnings:

$-10,007,742

Other Liabilities:

$425.30K

Cash:

$2.37M

Total Current Liabilities:

$622.47K

Property - Plant & Equipment:

$1.44M

Net Tangible Assets:

$4.44M

Total Current Assets:

$4.12M

Net Receivables:

$1.70M

Short-Term Investments:

$1.44M

Accounts Payable:

$182K

Short-Term Investments:

$1.44

Non Current Liabilities Total:

$494.35K

PIQ Share Price History

PIQ News

13 May, 2021
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Proteomics...
02 Feb, 2021
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
04 Dec, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Proteomics International...
16 Sep, 2020
Richard Lipscombe became the CEO of Proteomics International Laboratories Limited (ASX:PIQ) in 2014, and we think it's...